281 related articles for article (PubMed ID: 16403243)
1. Incremental cost-effectiveness of a collaborative care intervention for panic disorder.
Katon W; Russo J; Sherbourne C; Stein MB; Craske M; Fan MY; Roy-Byrne P
Psychol Med; 2006 Mar; 36(3):353-63. PubMed ID: 16403243
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial to improve the quality of treatment for panic and generalized anxiety disorders in primary care.
Rollman BL; Belnap BH; Mazumdar S; Houck PR; Zhu F; Gardner W; Reynolds CF; Schulberg HC; Shear MK
Arch Gen Psychiatry; 2005 Dec; 62(12):1332-41. PubMed ID: 16330721
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of improving primary care treatment of late-life depression.
Katon WJ; Schoenbaum M; Fan MY; Callahan CM; Williams J; Hunkeler E; Harpole L; Zhou XH; Langston C; Unützer J
Arch Gen Psychiatry; 2005 Dec; 62(12):1313-20. PubMed ID: 16330719
[TBL] [Abstract][Full Text] [Related]
4. A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder.
Roy-Byrne PP; Craske MG; Stein MB; Sullivan G; Bystritsky A; Katon W; Golinelli D; Sherbourne CD
Arch Gen Psychiatry; 2005 Mar; 62(3):290-8. PubMed ID: 15753242
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression.
Pyne JM; Fortney JC; Tripathi SP; Maciejewski ML; Edlund MJ; Williams DK
Arch Gen Psychiatry; 2010 Aug; 67(8):812-21. PubMed ID: 20679589
[TBL] [Abstract][Full Text] [Related]
6. Does the addition of cognitive behavioral therapy improve panic disorder treatment outcome relative to medication alone in the primary-care setting?
Craske MG; Golinelli D; Stein MB; Roy-Byrne P; Bystritsky A; Sherbourne C
Psychol Med; 2005 Nov; 35(11):1645-54. PubMed ID: 16219122
[TBL] [Abstract][Full Text] [Related]
7. Long-term effectiveness and cost of a systematic care program for bipolar disorder.
Simon GE; Ludman EJ; Bauer MS; Unützer J; Operskalski B
Arch Gen Psychiatry; 2006 May; 63(5):500-8. PubMed ID: 16651507
[TBL] [Abstract][Full Text] [Related]
8. Cognitive-behavioral treatment for panic disorder with agoraphobia: a randomized, controlled trial and cost-effectiveness analysis.
Roberge P; Marchand A; Reinharz D; Savard P
Behav Modif; 2008 May; 32(3):333-51. PubMed ID: 18391051
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of interventions for depressed Latinos.
Schoenbaum M; Miranda J; Sherbourne C; Duan N; Wells K
J Ment Health Policy Econ; 2004 Jun; 7(2):69-76. PubMed ID: 15208467
[TBL] [Abstract][Full Text] [Related]
10. Empirically supported treatments for panic disorder: costs, benefits, and stepped care.
Otto MW; Pollack MH; Maki KM
J Consult Clin Psychol; 2000 Aug; 68(4):556-63. PubMed ID: 10965630
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of an intervention to prevent depression in at-risk teens.
Lynch FL; Hornbrook M; Clarke GN; Perrin N; Polen MR; O'Connor E; Dickerson J
Arch Gen Psychiatry; 2005 Nov; 62(11):1241-8. PubMed ID: 16275811
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of a psychoeducational relapse prevention program for depression in primary care.
Stant AD; TenVergert EM; Kluiter H; Conradi HJ; Smit A; Ormel J
J Ment Health Policy Econ; 2009 Dec; 12(4):195-204. PubMed ID: 20195007
[TBL] [Abstract][Full Text] [Related]
13. Clinical effectiveness of individual cognitive behavioral therapy for depressed older people in primary care: a randomized controlled trial.
Serfaty MA; Haworth D; Blanchard M; Buszewicz M; Murad S; King M
Arch Gen Psychiatry; 2009 Dec; 66(12):1332-40. PubMed ID: 19996038
[TBL] [Abstract][Full Text] [Related]
14. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
[TBL] [Abstract][Full Text] [Related]
15. Incremental cost-effectiveness of pharmacotherapy and two brief cognitive-behavioral therapies compared with usual care for panic disorder and noncardiac chest pain.
Poirier-Bisson J; Marchand A; Pelland ME; Lessard MJ; Dupuis G; Fleet R; Roberge P
J Nerv Ment Dis; 2013 Sep; 201(9):753-9. PubMed ID: 23995030
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus.
Simon GE; Katon WJ; Lin EH; Rutter C; Manning WG; Von Korff M; Ciechanowski P; Ludman EJ; Young BA
Arch Gen Psychiatry; 2007 Jan; 64(1):65-72. PubMed ID: 17199056
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma.
Sullivan SD; Buxton M; Andersson LF; Lamm CJ; Liljas B; Chen YZ; Pauwels RA; Weiss KB
J Allergy Clin Immunol; 2003 Dec; 112(6):1229-36. PubMed ID: 14657888
[TBL] [Abstract][Full Text] [Related]
18. Active exercise, education, and cognitive behavioral therapy for persistent disabling low back pain: a randomized controlled trial.
Johnson RE; Jones GT; Wiles NJ; Chaddock C; Potter RG; Roberts C; Symmons DP; Watson PJ; Torgerson DJ; Macfarlane GJ
Spine (Phila Pa 1976); 2007 Jul; 32(15):1578-85. PubMed ID: 17621203
[TBL] [Abstract][Full Text] [Related]
19. A randomized, controlled clinical trial of standard, group and brief cognitive-behavioral therapy for panic disorder with agoraphobia: a two-year follow-up.
Marchand A; Roberge P; Primiano S; Germain V
J Anxiety Disord; 2009 Dec; 23(8):1139-47. PubMed ID: 19709851
[TBL] [Abstract][Full Text] [Related]
20. Does occasional cannabis use impact anxiety and depression treatment outcomes?: Results from a randomized effectiveness trial.
Bricker JB; Russo J; Stein MB; Sherbourne C; Craske M; Schraufnagel TJ; Roy-Byrne P
Depress Anxiety; 2007; 24(6):392-8. PubMed ID: 17096386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
